Clinical Trials Directory

Trials / Unknown

UnknownNCT00463957

The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (planned)
Sponsor
University of Cambridge · Academic / Other
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Sildenafil and similar drugs have been used for several years to treat erectile dysfunction. It has been noticed that in some people, sildenafil causes a subtle increase in the length of time that visual images that we see are retained by the retina. It is thought that this might be due to an effect of sildenafil on inhibiting an enzyme called phosphodiesterase type 6 (PDE6) which is present in the retina. By giving single oral doses of sildenafil and a similar drug called tadalafil which has less effect on PDE6, we hypothesise that this is the mechanism of the change in vision caused by sildenafil. By performing computerised visual test, we plan to compare the effects of sildenafil, tadalafil and placebo tablets on vision in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGsildenafil
DRUGtadalafil
DRUGplacebo

Timeline

Start date
2006-08-01
First posted
2007-04-20
Last updated
2010-01-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00463957. Inclusion in this directory is not an endorsement.